Oncternal TherapeuticsONCT
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 23 institutions reported holding Oncternal Therapeutics Inc. (ONCT) in their 13F filings, down 3 from Q2 2024. 3 opened new positions and 6 sold out. The largest holders were Vanguard Group Inc. ($185K), Millennium Management ($81K) and BlackRock, Inc. ($52K). 2 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Oncternal Therapeutics Inc.
- CUSIP
- 68236P206
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $16K |
| Exits | 6 | $633K |
All 13F filers, Q2 2024 → Q3 2024: 16,536 shares bought and 142,815 shares sold, net −126,279 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 23 holders
| Vanguard Group Inc. | 0.00% | Reduce -2.2% | 139,884 | $185K |
| Millennium Management | 0.00% | Reduce -40.5% | 61,205 | $81K |
| BlackRock, Inc. | 0.00% | — | 39,706 | $52K |
| Geode Capital Management, LLC | 0.00% | No change | 25,879 | $34K |
| Pasadena Private Wealth, LLC | 0.01% | No change | 25,000 | $33K |
| Renaissance Technologies | 0.00% | Add +4.1% | 17,905 | $24K |
| Morgan Stanley | 0.00% | Reduce -6.1% | 14,152 | $19K |
| Quantum Private Wealth, LLC | 0.01% | Reduce -51.0% | 13,187 | $17K |
| Virtu Financial LLC | 0.00% | New | 12,276 | $16K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +354.4% | 2,822 | $4K |
| Acadian Asset Management LLC | 0.00% | No change | 1,829 | $2K |
| UBS Group AG | 0.00% | Add +1121.0% | 1,221 | $2K |
| JPMorgan Chase & Co. | 0.00% | Add +10.7% | 1,111 | $1K |
| Wells Fargo & Company | 0.00% | Add +36.0% | 408 | $539 |
| North Star Investment Management Corp. | 0.00% | No change | 250 | $330 |
| BNP Paribas Financial Markets | 0.00% | No change | 182 | $240 |
| Osaic Holdings, Inc. | 0.00% | No change | 150 | $198 |
| Bank of America Corp. | 0.00% | No change | 22 | $29 |
| Truvestments Capital LLC | 0.00% | New | 22 | $29 |
| Nemes Rush Group LLC | 0.00% | No change | 3 | $27 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 15 | $20 |
| Lindbrook Capital, LLC | 0.00% | No change | 15 | $20 |
| Danske Bank A/S | 0.00% | New | 1 | $1 |
"% of holder's portfolio" is ONCT's weight in each manager's 13F, not the share of Oncternal Therapeutics Inc. the manager owns.